source
- Moderna discusses post-marketing data with FDA to expand Covid-19 vaccine labelModerna announced it is working with US regulators to supply post-marketing data on its Covid-19 vaccines. The effort aims to address the FDA's decision last year to narrow the vaccine label, limi…
- FDA greenlights Pfizer/Arvinas breast cancer therapy vepdegestrant despite modest trial resultsThe U.S. Food and Drug Administration announced approval of vepdegestrant, a therapy developed by Pfizer and Arvinas, for a specific subtype of breast cancer. The decision comes even though the cl…